Skip to content

Evaluation of the effects of the fermented milk drink-1 containing Lactobacillus casei NY1301

Evaluation of the effects of the fermented milk drink-1 containing Lactobacillus casei NY1301 - Evaluation of the effects of the fermented milk drink-1

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000025098
Enrollment
70
Registered
2016-12-26
Start date
2016-12-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subjects who have a tendency to be constipated

Interventions

Intake of the fermented milk drink for 2 weeks Intake of the placebo drink for 2 weeks

Sponsors

QOL RD Co.,Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)Males and females from 20 to 70 years-old (2)Subjects who have a tendency to be constipated defecate two to five times a week (3)Subjects undergoing none of medical treatments (4)Subjects eat regularly

Exclusion criteria

Exclusion criteria: (1)Subjects with a serious disease (2)Subjects have a medical history or a surgical history of digestive diseases (3)Subjects allergic to a specific drug or food (4)Subjects work alternative or midnight shifts (5)Subjects never be able to stop intaking foods or drinks which improve constipation during study,such as foods containing lactic acid bacteria,bifidobacteria,natto bacteria,oligosaccharides,dietary fibers and/or other health foods including food for specified health use (6)Subjects taking any kinds of drugs affect this study(constipation drugs,intestinal drugs,etc.) (7)Subjects drink alcohol over 500mL in terms of beer per day (8)Subjects smoke over 20 cigarettes per day (9)Subjects drawn blood over 200mL last 1 month,or over 400mL last 3 months (10)Subjects allergic to samples in this study (11)Pregnants,lactating women or who is going to be pregnant (12)Subjects who have participated in the other clinical studies (13)Subjects judged as unsuitable for the study by the principal investigator for other reasons

Design outcomes

Primary

MeasureTime frame
Defecation frequency, fecal amount

Secondary

MeasureTime frame
Fecal shape, fecal color, feelings after defecation, analysis of intestinal microflora

Countries

Japan

Contacts

Public ContactSoichi Yoneda

QOL RD Co.,Ltd. CRO Department Food Division

s-yoneda@qol-rd.co.jp03-6386-8809

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026